Maxillofacial Plastic and Reconstructive Surgery

  • Volume 42
  • /
  • Pages.9.1-9.2
  • /
  • 2020
  • /
  • 2288-8101(pISSN)
  • /
  • 2288-8586(eISSN)
Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지
DOI QR코드

DOI QR Code

Dysosmia and dysgeusia due to the 2019 Novel Coronavirus; a hypothesis that needs further investigation

  • Keyhan, Seied Omid (National Advance Center for Craniomaxillofacial Reconstruction) ;
  • Fallahi, Hamid Reza (School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences) ;
  • Cheshmi, Behzad (Faculty of Dentistry, Boroujerd Islamic Azad University)
  • Received : 2020.03.21
  • Accepted : 2020.03.24
  • Published : 2020.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Gorbalenya A (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. https://doi.org/10.1038/s41564-020-0695-z
  2. Letko MC, Munster V (2020) Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV. bioRxiv
  3. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270-273
  4. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507-513
  5. Bergmann CC, Lane TE, Stohlman SA (2006) Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 4(2):121-132
  6. Barthold SW, Smith A (1990) Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab Anim Sci 40(5):481-485
  7. Perlman S, Evans G, Afifi A (1990) Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J Exp Med 172(4):1127-1132
  8. Farda R (2020) Loss of sense of smell among Iranians coinciding with Coronavirus epidemic. Available via DIALOG. https://en.radiofarda.com/a/loss-of-sense-of-smell-among-iranians-coinciding-with-coronavirusepidemic/30478044.html. Accessed 24 Mar 2020.
  9. IFP Editorial staff (2020) Olfactory disorder getting prevalent in Iran amid Coronavirus outbreak. Available via DIALOG. https://ifpnews.com/olfactory-disorder-getting-prevalent-in-iran-amid-coronavirus. Accessed 24 Mar 2020.

Cited by

  1. Case report of familial COVID-19 cluster associated with High prevalence of anosmia, ageusia, and gastrointestinal symptoms vol.22, 2020, https://doi.org/10.1016/j.idcr.2020.e00975
  2. Anosmia and dysgeusia in COVID-19: A systematic review vol.5, 2020, https://doi.org/10.12688/wellcomeopenres.15917.1
  3. Anosmia and ageusia as initial or unique symptoms after COVID-19 (Review article) vol.65, pp.6, 2020, https://doi.org/10.17116/anaesthesiology202006213
  4. ¿Qué darle a un paciente con sospecha de contagio por COVID-19? vol.87, pp.2, 2020, https://doi.org/10.35366/94173
  5. Disentangling the Hypothesis of Host Dysosmia and SARS-CoV-2: The Bait Symptom That Hides Neglected Neurophysiological Routes vol.11, 2020, https://doi.org/10.3389/fphys.2020.00671
  6. The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis vol.163, pp.1, 2020, https://doi.org/10.1177/0194599820926473
  7. Prevalence and Recovery From Olfactory and Gustatory Dysfunctions in Covid-19 Infection: A Prospective Multicenter Study vol.34, pp.5, 2020, https://doi.org/10.1177/1945892420930954
  8. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19 vol.104, 2020, https://doi.org/10.1016/j.bioorg.2020.104269
  9. A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities vol.10, pp.1, 2020, https://doi.org/10.1038/s41398-020-01039-2
  10. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19 vol.2, 2020, https://doi.org/10.1016/j.crphar.2021.100035
  11. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19 vol.2, 2021, https://doi.org/10.1016/j.crphar.2021.100063
  12. Olfactory and gustatory dysfunction in 2019 novel Coronavirus: An updated systematic review and meta-analysis vol.12, pp.1, 2021, https://doi.org/10.4103/ijpvm.ijpvm_484_20
  13. Evaluation of Anosmia and Ageusia in COVID-19 Patients: An Observational Study vol.12, pp.1, 2020, https://doi.org/10.5005/jp-journals-10015-1799
  14. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence vol.278, pp.2, 2020, https://doi.org/10.1007/s00405-020-06120-6
  15. A Review of the Importance of Atypical Otorhinolaryngological Symptoms in the Screening of COVID-19 Patients vol.73, pp.1, 2020, https://doi.org/10.1007/s12070-020-02045-y
  16. Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review vol.9, pp.3, 2020, https://doi.org/10.3390/dj9030032
  17. Chemosensory Systems in COVID-19: Evolution of Scientific Research vol.12, pp.5, 2020, https://doi.org/10.1021/acschemneuro.0c00788
  18. SHORT‐TERM chemosensory distortions and phantoms in COVID ‐19 vol.6, pp.2, 2020, https://doi.org/10.1002/lio2.532
  19. Neurological Complications of COVID-19: Underlying Mechanisms and Management vol.22, pp.8, 2020, https://doi.org/10.3390/ijms22084081
  20. Neuropathies and neurological dysfunction induced by coronaviruses vol.27, pp.3, 2021, https://doi.org/10.1007/s13365-021-00977-x
  21. Covid‐19 and oral diseases: Crosstalk, synergy or association? vol.31, pp.6, 2020, https://doi.org/10.1002/rmv.2226